21083889

Source:http://linkedlifedata.com/resource/pubmed/id/21083889

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0001758, umls-concept:C0003873, umls-concept:C0004083, umls-concept:C0025677, umls-concept:C0030705, umls-concept:C0079809, umls-concept:C0162491, umls-concept:C0205177, umls-concept:C0205210, umls-concept:C0871261, umls-concept:C1274040, umls-concept:C1704632, umls-concept:C1706817, umls-concept:C2353893, umls-concept:C2603343, umls-concept:C2911692
pubmed:issue	6
pubmed:dateCreated	2011-3-2
pubmed:databankReference	http://linkedlifedata.com/resource/pubmed/xref/ClinicalTrials.gov/NCT00264550
pubmed:abstractText	The goal of this study was to identify serum markers that are modulated by treatment with golimumab with or without methotrexate (MTX) and are associated with clinical response.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/21083889-10501417, http://linkedlifedata.com/resource/pubmed/commentcorrection/21083889-10990219, http://linkedlifedata.com/resource/pubmed/commentcorrection/21083889-11557647, http://linkedlifedata.com/resource/pubmed/commentcorrection/21083889-11874832, http://linkedlifedata.com/resource/pubmed/commentcorrection/21083889-13130482, http://linkedlifedata.com/resource/pubmed/commentcorrection/21083889-14614165, http://linkedlifedata.com/resource/pubmed/commentcorrection/21083889-15975966, http://linkedlifedata.com/resource/pubmed/commentcorrection/21083889-16356192, http://linkedlifedata.com/resource/pubmed/commentcorrection/21083889-16508926, http://linkedlifedata.com/resource/pubmed/commentcorrection/21083889-16736519, http://linkedlifedata.com/resource/pubmed/commentcorrection/21083889-17273811, http://linkedlifedata.com/resource/pubmed/commentcorrection/21083889-17911432, http://linkedlifedata.com/resource/pubmed/commentcorrection/21083889-18400834, http://linkedlifedata.com/resource/pubmed/commentcorrection/21083889-18664547, http://linkedlifedata.com/resource/pubmed/commentcorrection/21083889-19066176, http://linkedlifedata.com/resource/pubmed/commentcorrection/21083889-19265537, http://linkedlifedata.com/resource/pubmed/commentcorrection/21083889-19279017, http://linkedlifedata.com/resource/pubmed/commentcorrection/21083889-19460157, http://linkedlifedata.com/resource/pubmed/commentcorrection/21083889-19487269, http://linkedlifedata.com/resource/pubmed/commentcorrection/21083889-19710928, http://linkedlifedata.com/resource/pubmed/commentcorrection/21083889-19790070, http://linkedlifedata.com/resource/pubmed/commentcorrection/21083889-20432243, http://linkedlifedata.com/resource/pubmed/commentcorrection/21083889-2049578, http://linkedlifedata.com/resource/pubmed/commentcorrection/21083889-2059229, http://linkedlifedata.com/resource/pubmed/commentcorrection/21083889-20655893, http://linkedlifedata.com/resource/pubmed/commentcorrection/21083889-7516430, http://linkedlifedata.com/resource/pubmed/commentcorrection/21083889-8782125
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/101154438
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Antirheumatic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers, http://linkedlifedata.com/resource/pubmed/chemical/Methotrexate, http://linkedlifedata.com/resource/pubmed/chemical/golimumab
pubmed:status	MEDLINE
pubmed:issn	1478-6362
pubmed:author	pubmed-author:BuchananJacquiJ, pubmed-author:ElashoffMichaelM, pubmed-author:GenoveseMarkM, pubmed-author:HsiaElizabethE, pubmed-author:KeystoneEdwardE, pubmed-author:KlareskogLarsL, pubmed-author:MackMichaelM, pubmed-author:RahmanMahboob UMU, pubmed-author:VisvanathanSudhaS, pubmed-author:WagnerCarrieC
pubmed:issnType	Electronic
pubmed:volume	12
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	R211
pubmed:dateRevised	2011-7-26
pubmed:meshHeading	pubmed-meshheading:21083889-Antibodies, Monoclonal, pubmed-meshheading:21083889-Antirheumatic Agents, pubmed-meshheading:21083889-Arthritis, Rheumatoid, pubmed-meshheading:21083889-Biological Markers, pubmed-meshheading:21083889-Enzyme-Linked Immunosorbent Assay, pubmed-meshheading:21083889-Humans, pubmed-meshheading:21083889-Methotrexate
pubmed:year	2010
pubmed:articleTitle	Association of serum markers with improvement in clinical response measures after treatment with golimumab in patients with active rheumatoid arthritis despite receiving methotrexate: results from the GO-FORWARD study.
pubmed:affiliation	Centocor Research and Development, Inc, 200 Great Valley Parkway, Malvern, PA 19355, USA.
pubmed:publicationType	Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't